Leucid Bio
Peter J. is a seasoned professional in the field of oncology and cancer biology, currently serving as a Senior Scientist at Leucid Bio since May 2022. Prior experience includes a role as a Postdoctoral Research Scientist at King's College London from May 2021 to May 2022, and a position as a Research Technician at UCL from September 2014 to August 2016. Peter J. has a robust educational background, holding a Doctor of Philosophy in Oncology and Cancer Biology from King's College London (2016-2020), a Master of Science in Molecular Pathology and Genomics from Queen Mary University of London (2012-2013), and a Bachelor of Science in Biochemistry from UCL (2008-2011).
Leucid Bio
1 followers
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part ofLeucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.